Pro-choice, Pro-Information, Anti-Eugenics
By David Perry,
ThisMess.net
| 06. 23. 2014
Untitled Document
Yesterday I published
a guest post by Nancy McCrea Iannone, an expert on Down syndrome and pregnancy.
I would like you, please, to go read it and share it. Independent blogs like mine need your help to spread the word on any given message.
The post talked about an assault on the pro-information coalition by anti-abortion activists and legislators in Louisiana. Pro-information stands for the many pro-life AND pro-choice people who have come together to try and change how the pre-natal diagnosis is being presented.
We know that at least some of the very high percentage of terminations after a pre-natal diagnosis of Down syndrome take place after being told things that are either simply false or skew towards the negatives. We know that doctors deliver the diagnosis, then ask, "so would you like me to schedule a termination for you?" We know we can do this better, and we are, thanks to the efforts of so many.
It happens with post-natal diagnoses too. When Nico was born, in that terrifying and grief-stricken first hour, we were given...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...